Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy

Clinical Rheumatology

Volumn 26, Issue 7, 2007, Pages 1132-1133

  Sakellariou, Grigorios T ^a   Vounotrypidis, Periklis ^b   Berberidis, Charalampos ^b  

^a St Paul's Hospital   (Greece)

^b 424 General Army Hospital   (Greece)

Author keywords

Glomerulonephritis; IgA nephropathy; Infliximab; Psoriatic arthritis; Renal disease

Indexed keywords

CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOGLOBULIN A; INFLIXIMAB; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; MONOTHERAPY; POLYARTHRITIS; PRIORITY JOURNAL; PROTEINURIA; PSORIATIC ARTHRITIS; REMISSION; RETREATMENT; TREATMENT OUTCOME; URINALYSIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; PROTEINURIA; TREATMENT OUTCOME;

EID: 34249870091     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0422-z     Document Type: Article

References (13)

1. Donadio JV, Grande JP (2002) IgA nephropathy. N Engl J Med 347:738-748
2. Montenegro V, Monteiro RC (1999) Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role. Curr Opin Rheumatol 11:265-272
3. Veys EM, van Laere M (1973) Serum IgG, IgM and IgA levels in ankylosing spondylitis. Ann Rheum Dis 32:493-496
4. Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25:1544-1552
5. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD (1994) Elevated tumour necrosis factor-alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol 96:146-151
6. Lim CS, Yoon HJ, Kim YS, Ahn C, Han JS, Kim S et al (2003) Clinicopathological correlation of intrarenal cytokines and chemokines in IgA nephropathy. Nephrology 8:21-27
7. Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN (2005) Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy. Kidney Int 67:602-612
8. Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN (2003) Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol Dial Transplant 18:36-45
9. Lan HY, Yang N, Nikolic-Paterson DJ, Yu XQ, Mu W, Isbel NM et al (2000) Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 57:499-509
10. Praga M, Gutierrez E, Gonzalez E, Morales E, Hernandez E (2003) Treatment of IgA nephropathy with ACE inhibitors: A randomized and controlled trial. J Am Soc Nephrol 14:1578-1583
11. Forshaw MJ, Guirguis O, Hennigan TW (2005) IgA nephropathy in association with Crohn's disease. Int J Colorectal Dis 20:463-465
12. de Moura CG, de Moura TG, de Souza SP, Testagrossa L (2006) Inflammatory bowel disease, ankylosing spondylitis, and IgA nephropathy. J Clin Rheumatol 12:106-107
13. Yamamoto M, Yorioka T, Kawada M, Nishimura K, Kumon Y, Yasuoka N et al (1994) A case of IgA nephropathy associated with psoriasis vulgaris. Nippon Jinzo Gakkai Shi 36:779-783